vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and i3 Verticals, Inc. (IIIV). Click either name above to swap in a different company.

i3 Verticals, Inc. is the larger business by last-quarter revenue ($52.7M vs $38.9M, roughly 1.4× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 0.9%, a 23.8% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -14.6%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $13.8M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -4.7%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

The Prusa i3 is a family of fused filament fabrication 3D printers, manufactured by Czech company Prusa Research under the trademarked name Original Prusa i3. Part of the RepRap project, Prusa i3 printers were called the most used 3D printer in the world in 2016. The first Prusa i3 was designed by Josef Průša in 2012, and was released as a commercial kit product in 2015. The latest model is available in both kit and factory assembled versions. The Prusa i3's comparable low cost and ease of co...

CDXS vs IIIV — Head-to-Head

Bigger by revenue
IIIV
IIIV
1.4× larger
IIIV
$52.7M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+96.0% gap
CDXS
81.3%
-14.6%
IIIV
Higher net margin
CDXS
CDXS
23.8% more per $
CDXS
24.7%
0.9%
IIIV
More free cash flow
CDXS
CDXS
$5.8M more FCF
CDXS
$19.6M
$13.8M
IIIV
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-4.7%
IIIV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
IIIV
IIIV
Revenue
$38.9M
$52.7M
Net Profit
$9.6M
$484.0K
Gross Margin
94.8%
Operating Margin
27.1%
3.1%
Net Margin
24.7%
0.9%
Revenue YoY
81.3%
-14.6%
Net Profit YoY
192.5%
-76.5%
EPS (diluted)
$0.13
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
IIIV
IIIV
Q4 25
$38.9M
$52.7M
Q3 25
$8.6M
$46.0M
Q2 25
$15.3M
$51.9M
Q1 25
$7.5M
$63.1M
Q4 24
$21.5M
$52.2M
Q3 24
$12.8M
$32.0M
Q2 24
$8.0M
$46.2M
Q1 24
$17.1M
$58.0M
Net Profit
CDXS
CDXS
IIIV
IIIV
Q4 25
$9.6M
$484.0K
Q3 25
$-19.6M
$3.1M
Q2 25
$-13.3M
$12.9M
Q1 25
$-20.7M
$-154.0K
Q4 24
$-10.4M
$2.1M
Q3 24
$-20.6M
$117.9M
Q2 24
$-22.8M
$-7.5M
Q1 24
$-11.5M
$1.9M
Gross Margin
CDXS
CDXS
IIIV
IIIV
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
IIIV
IIIV
Q4 25
27.1%
3.1%
Q3 25
-220.3%
3.2%
Q2 25
-83.9%
-9.3%
Q1 25
-271.6%
8.0%
Q4 24
-34.2%
3.9%
Q3 24
-129.0%
10.6%
Q2 24
-284.9%
-2.8%
Q1 24
-69.6%
3.4%
Net Margin
CDXS
CDXS
IIIV
IIIV
Q4 25
24.7%
0.9%
Q3 25
-228.1%
6.7%
Q2 25
-86.6%
24.8%
Q1 25
-274.3%
-0.2%
Q4 24
-48.4%
3.9%
Q3 24
-160.8%
368.2%
Q2 24
-285.2%
-16.3%
Q1 24
-67.4%
3.2%
EPS (diluted)
CDXS
CDXS
IIIV
IIIV
Q4 25
$0.13
$0.02
Q3 25
$-0.22
$0.14
Q2 25
$-0.16
$0.50
Q1 25
$-0.25
$0.00
Q4 24
$-0.12
$0.08
Q3 24
$-0.29
$4.93
Q2 24
$-0.32
$-0.32
Q1 24
$-0.16
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
IIIV
IIIV
Cash + ST InvestmentsLiquidity on hand
$78.2M
$37.5M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$358.5M
Total Assets
$147.8M
$595.9M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
IIIV
IIIV
Q4 25
$78.2M
$37.5M
Q3 25
$58.7M
$66.7M
Q2 25
$66.3M
$55.5M
Q1 25
$59.8M
$7.7M
Q4 24
$73.5M
$85.6M
Q3 24
$90.3M
$86.5M
Q2 24
$73.2M
$9.7M
Q1 24
$85.5M
$3.1M
Total Debt
CDXS
CDXS
IIIV
IIIV
Q4 25
$40.1M
Q3 25
$39.7M
$0
Q2 25
$39.4M
$0
Q1 25
$29.2M
$12.0M
Q4 24
$28.9M
$26.2M
Q3 24
$28.6M
$26.2M
Q2 24
$28.4M
$374.1M
Q1 24
$28.1M
$369.6M
Stockholders' Equity
CDXS
CDXS
IIIV
IIIV
Q4 25
$50.5M
$358.5M
Q3 25
$38.5M
$389.6M
Q2 25
$55.6M
$383.3M
Q1 25
$49.6M
$385.2M
Q4 24
$66.9M
$375.0M
Q3 24
$73.4M
$379.7M
Q2 24
$61.4M
$249.7M
Q1 24
$79.3M
$249.3M
Total Assets
CDXS
CDXS
IIIV
IIIV
Q4 25
$147.8M
$595.9M
Q3 25
$124.0M
$638.4M
Q2 25
$138.2M
$623.3M
Q1 25
$128.9M
$646.4M
Q4 24
$149.0M
$726.2M
Q3 24
$148.2M
$730.7M
Q2 24
$132.0M
$861.7M
Q1 24
$149.6M
$625.8M
Debt / Equity
CDXS
CDXS
IIIV
IIIV
Q4 25
0.79×
Q3 25
1.03×
0.00×
Q2 25
0.71×
0.00×
Q1 25
0.59×
0.03×
Q4 24
0.43×
0.07×
Q3 24
0.39×
0.07×
Q2 24
0.46×
1.50×
Q1 24
0.35×
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
IIIV
IIIV
Operating Cash FlowLast quarter
$20.1M
$14.1M
Free Cash FlowOCF − Capex
$19.6M
$13.8M
FCF MarginFCF / Revenue
50.3%
26.2%
Capex IntensityCapex / Revenue
1.3%
0.6%
Cash ConversionOCF / Net Profit
2.09×
29.18×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
IIIV
IIIV
Q4 25
$20.1M
$14.1M
Q3 25
$-7.7M
$14.0M
Q2 25
$-18.0M
$7.4M
Q1 25
$-13.8M
$-27.1M
Q4 24
$-16.5M
$11.5M
Q3 24
$-13.0M
$15.1M
Q2 24
$-12.2M
$8.1M
Q1 24
$-7.8M
$10.7M
Free Cash Flow
CDXS
CDXS
IIIV
IIIV
Q4 25
$19.6M
$13.8M
Q3 25
$-7.9M
$13.5M
Q2 25
$-20.5M
$6.8M
Q1 25
$-15.1M
$-27.6M
Q4 24
$-18.2M
$11.0M
Q3 24
$-14.0M
$14.6M
Q2 24
$-12.6M
$7.2M
Q1 24
$-8.9M
$9.9M
FCF Margin
CDXS
CDXS
IIIV
IIIV
Q4 25
50.3%
26.2%
Q3 25
-91.7%
29.5%
Q2 25
-133.6%
13.1%
Q1 25
-199.6%
-43.8%
Q4 24
-85.0%
21.1%
Q3 24
-109.0%
45.6%
Q2 24
-157.5%
15.6%
Q1 24
-52.2%
17.1%
Capex Intensity
CDXS
CDXS
IIIV
IIIV
Q4 25
1.3%
0.6%
Q3 25
2.1%
0.9%
Q2 25
16.4%
1.0%
Q1 25
16.7%
0.8%
Q4 24
8.3%
0.9%
Q3 24
7.8%
1.7%
Q2 24
5.0%
1.9%
Q1 24
6.6%
1.4%
Cash Conversion
CDXS
CDXS
IIIV
IIIV
Q4 25
2.09×
29.18×
Q3 25
4.52×
Q2 25
0.57×
Q1 25
Q4 24
5.59×
Q3 24
0.13×
Q2 24
Q1 24
5.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

IIIV
IIIV

License And Service$35.7M68%
Proprietary Payments Revenue$14.5M27%
Other Revenue$2.5M5%

Related Comparisons